Identity
- Trade Name
- BioJVA FDA UDI
- Generic Name
- Jaw physiology evaluation system FDA UDI
- Model / Reference
- Headset FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00860003499931 FDA UDI
- 510(k) Number
- K905657 FDA UDI
- FDA Product Code
- NFQ FDA UDI
- GMDN Term
- Jaw physiology evaluation system FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 872.2050 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Jaw physiology evaluation system
BioJVA by Bio-Research Associates, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Jaw physiology evaluation system.
- K7 ESG-2 Electrosonograph — MYOTRONICS-NOROMED, INC. · Class I
- KIT PATIENT — MODJAW · Class I
- Tech In Motion — MODJAW · Class I
- K7 Evaluation System-CMS — MYOTRONICS-NOROMED, INC. · Class I
- SHINING 3D® — Shining 3D Tech Co., Ltd. · Class I
- K7 CMS Sensor Array — MYOTRONICS-NOROMED, INC. · Class I
- K7 Evaluation System-ESG — MYOTRONICS-NOROMED, INC. · Class II
- SHINING 3D® — Shining 3D Tech Co., Ltd. · Class I
Cleared under the same submission
K905657 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Bio-Research Associates, Inc.
Sources (1)
- FDA UDI 55d3bb14-400b-471e-a9d0-b7c5afb36930 34 fields · synced May 30, 2026